Pharma BD Deal Intelligence

Shire plc / Dyax Corp.

2015 · Acquisition/Merger · $5.9B · Complete

Announcement Sentiment

88

Strongly positive

Outcome Score

89

Worked — the deal delivered on its rationale.

Shire acquired Dyax for $5.9B for hereditary angioedema treatments.

Key facts

Announced Nov 02, 2015
Closed Jan 22, 2016
Deal value $5.9B
Deal type Acquisition/Merger
Therapeutic area Rare Disease

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals